Health

BERWYN, Pa., Oct. 29, 2020 (GLOBE NEWSWIRE) — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, today announced it resumed treatment more...

NEW YORK, Oct. 28, 2020 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Loop Industries, more...

BILLERICA, Mass., Oct. 28, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer, will participate in the virtual 2020 Oppenheimer Fall more...

Alimera Sciences (ALIM) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.49. This compares to loss of $0.60 per share a year ago. These more...

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update PR Newswire SAN DIEGO, Oct. 28, 2020 SAN DIEGO , Oct. 28, 2020 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology more...

Kindred Biosciences to Announce Third Quarter 2020 Financial Results Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time on Monday, November 9, 2020. PR Newswire SAN FRANCISCO, Oct. 28, more...

The market expects AcelRx Pharmaceuticals (ACRX) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2020. This widely-known consensus outlook is important in assessing the more...

The market expects T2 Biosystems (TTOO) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2020. This widely-known consensus outlook is important in assessing the more...

Wall Street expects a year-over-year increase in earnings on lower revenues when ConforMIS (CFMS) reports results for the quarter ended September 2020. While this widely-known consensus outlook is important in gauging the company’s earnings picture, more...

Cutera (CUTR) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2020. This widely-known consensus outlook gives a good sense of the company’s more...